References
Davis MP, Walsh D, Lagman R, Yavuzsen T (2006) Early satiety in cancer patients: a common and important but underrecognized symptom. Support Care Cancer (in press)
Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8:175–179
Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, Legrand SB, Davis M, Naughton M, Gvozdjan D, Pham H (2006) Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer. DOI 10.1007/s00520-005-0009-2
Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Vigano A, Larkin P, De Conno F, Hanks G, Kaasa S, Steering Committee of the European Association for Palliative Care (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240–6248
Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer. DOI 10.1007/s00520-005-0899-z
Strasser F (2003) Pathophysiology of anorexia/cachexia syndrome. In: Doyle D, Hanks G, Cherny N, Calman K Sir (eds) Oxford textbook of palliative medicine 3rd edn (chapter 8.4.1). Oxford University Press, Oxford, pp 520–533
Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A (2000) A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19:427–435
Cerny T, Lueftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko Y-D, Schnelle M, Reif M, Strasser F, for the Cannabis-In-Cachexia-Study-Group (2003) Oral cannabis-extract versus delta-9-tetrahydrocannabinol for patients with cancer-related anorexia: a randomized, double-blind, placebo-controlled multicenter study (abstract 2934). Proc Am Soc Clin Oncol Meet 22:730
Baracos VE, Le Bricon T (2000) Animal models for nutrition in cancer. Nestle Nutr Workshop Ser Clin Perform Progr 4:167–180; discussion 180–182
Preliminary clinical data
Wolf I, Sadetzki S, Kanety H, Kundel Y, Pariente C, Epstein N, Oberman B, Catane R, Kaufman B, Shimon I (2006) Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 106:966–973
Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A (2000) A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19:427–435
Degen L, Petrig C, Studer D, Schroller S, Beglinger C (2005) Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 17:821–826
Izzo AA (2004) Cannabinoids and intestinal motility: welcome to CB2 receptors. Br J Pharmacol 142:1201–1202
Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA, Coombes RC, Bloom SR (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2832–2836
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strasser, F. The silent symptom early satiety: a forerunner of distinct phenotypes of anorexia/cachexia syndromes. Support Care Cancer 14, 689–692 (2006). https://doi.org/10.1007/s00520-006-0061-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-006-0061-6